EDP-938, EDP-938 Placebo tablets
EDP 938-104
Phase 2 small_molecule active
Quick answer
EDP-938, EDP-938 Placebo tablets for Respiratory syncytial virus (RSV) is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- Respiratory syncytial virus (RSV)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active